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1.1 English
To guarantee a successful function and reproduction a cell is faced with
the challenging task of maintaining the stability of its genome and replicating its
DNA. Throughout evolution many mechanisms have been established to
guarantee genomic stability from generation to generation. The cell possesses
very sophisticated cell cycle checkpoint pathways to survey the different phases
of the cell cycle including cell division and to detect DNA damages. The
heterotrimeric protein complex Rad9, Rad1 and Hus1, called the ’9-1-1 complex’,
is an important key player in such checkpoint pathways. The ‘9-1-1 complex’
exhibits structural similarity with the homotrimeric clamp formed by proliferating
cell nuclear antigen (PCNA). PCNA is known to form a complex with the tumour
suppressor protein flap endonuclease 1 (Fen1). The goal of this study was to
characterize the interaction of the ‘9-1-1 complex’ with Fen1, an enzyme involved
in DNA replication and various repair mechanisms. For this purpose the human
‘9-1-1 complex’ was isolated by co-expressing the three baculovirus encoding the
recombinant Rad9, Rad1 and Hus1 in Sf9 cells. In pull down experiments and by
Far Western Blot analysis it was shown that Fen1 physically interacts with the ‘9-
1-1 complex’ from Sf9 cell extract as well as with the purified ‘9-1-1 complex’.
Furthermore Fen1 binds to each of the three monomers Rad9, Rad1 and Hus1.
The binding seems to occur through the Fen1 C-terminus. These findings are
also interesting form a evolutionary point of view since the Archaea homologue of
Fen1 is missing its C-terminus and no checkpoint proteins are found in this early
organisms. Previous studies from our laboratory documented that acetylation of
Fen1 is increased upon UV damage. To test if this has an effect on the binding to
the ‘9-1-1 complex’ a pull down experiment with in vitro acetylated Fen1 was
performed. In summary, the results presented in this work support the hypothesis
that the ‘9-1-1 complex’ has an important role in DNA repair.
61.2 German
Um eine erfolgreiche Funktion und Fortpflanzung der Zelle zu garantieren,
ist diese mit der herausfordernden Aufgabe konfrontiert, die Stabilität ihres
Genoms zu wahren und ihre DNA zu kopieren. Im Laufe der Evolution sind viele
Mechanismen entstanden, die mithelfen die Stabilität der Erbinformation zu
garant ieren.  Die Zel le  ver fügt  über  sehr  ausgeklügel te
Zellzykluskontrollsysteme, um die verschiedenen Phasen des Zellzyklus
inklusive Zellteilung zu überwachen und um DNA Schäden festzustellen. Der
heterotrimere Proteinkomplex Rad9, Rad1 and Hus1, bezeichnet als den ‘9-1-1
Komplex’, hat eine Schlüsselstelle in solchen Kontrollsystemen. Der ’9-1-1
Komplex’ hat strukturelle Ähnlichkeiten mit dem ringförmigen Homotrimer
Proliferating Cell Nuclear Antigen (PCNA). Von PCNA weiss man, dass es mit
dem Tumorsuppressorprotein Flap endonuclease 1 (Fen1) einen Komplex bildet,
dessen Rolle in der DNA Replikation und verschieden Reparaturmechanismen
bekannt ist. Das Ziel dieser Dissertation war es, die Interaktion zwischen dem ‘9-
1-1 Komplex’ und Fen1 zu charakterisieren. Der ’9-1-1 Komplex’ wurde aus Sf9
Zellen isoliert, die mit 3 Baculoviren infiziert worden waren. Die Viren enthielten
die DNA von den rekombinanten Proteinen Rad9, Rad1 und Hus1 und wurden in
den Zellen überexprimiert. Mittels ’pull down’ Experimenten und ’Far Western
Blot’ Analysen konnte gezeigt werden, dass Fen1 physisch sowohl mit dem ’9-1-
1 Komplex’ aus Extrakt von Sf9 Zellen als auch mit gereinigtem ’9-1-1 Komplex’
interagiert. Fen1 bindet einzeln an jede der drei Untereinheiten Rad9, Rad1 und
Hus1. Die Bindung geschieht über den C-terminus von Fen1. Dieses Ergebnis ist
auch vom evolutionären Standpunkt aus interessant, hat nämlich weder das
Fen1 Homolog in Archaea einen C-terminus noch wurden in diesen Organismen
Checkpoint Proteine gefunden. Frühere Studien aus unserem Labor zeigten,
dass die Azetylierung von Fen1 nach einer UV Schädigung ansteigt. Um zu
testen, ob die Azetylierung von Fen1 einen Einfluss auf die Interaktion mit dem
’9-1-1 Komplex’ hat, wurde ein ’pull down’ Experiment mit in vitro azetyliertem
Fen1 durchgeführt. Die Ergebnisse dieser Arbeit bestärken die Hypothese, dass
der ’9-1-1 Komplex’ eine wichtige Funktion in der DNA Reparatur hat.
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2.1 Genomic stability and the cell cycle
All necessary information for the key characteristics of life is stored on the
DNA in each cell nucleus. Because DNA is a chemically highly reacting molecule
it is a dedicated target for different kinds of chemical and physical substances.
Not only environmental influences but also misincorporation of nucleotides during
DNA replication can cause DNA damages or lead to incorrect DNA sequence or
structure. To guarantee a successful function and reproduction a cell is faced
with the challenging task of maintaining the stability of its genome and replicating
its DNA. Over billion of years the evolution developed and conserved different
strategies to overcome these problems, enormous machineries of proteins
coordinate these fundamental and complicated events. Despite the evolutionary
distance the functions of proteins involved and the mechanisms at the basis of
these events are strikingly similar in prokaryotes, archeas and eukaryotes, the
three kingdoms of life (Tye, 2000). In multicellular organism also the
communication and the coordination among the cells is very important. The loss
of ability of cells to communicate and act selflessly as a part of an integrated
whole can lead to severe disorders, such as cancer and hereditary diseases.
The cell cycle is divided in four phases: G1-phase (gap 1), the phase of
actual cell activity. This phase is followed by the S-phase (synthesis) where the
genomic DNA is copied. The third phase is called G2-phase (gap 2), a short
interval in which cell division is prepared and initiated. The M-phase (mitosis)
unites all the different stages of mitosis: Condensation of the chromosomes,
alignment of the homologous chromosomes in the central plane of the cell,
separation of the chromosomes into two equivalent sets of genomic DNA copies
and finally cell division. Differentiated cells that cannot divide any longer proceed
into an additional phase called G0 (gap 0) corresponding to a constant G1-
phase.
8Throughout evolution many mechanisms have been established to
guarantee genomic stability from generation to generation. Firstly, DNA
replication is performed by DNA polymerases and auxiliary proteins with high
fidelity, among them flap endonuclease 1 (Fen1) (Harrington and Lieber, 1994a)
one of the key players of this thesis. Secondly, the cell possesses very
sophisticated cell cycle checkpoint pathways to survey the different phases of the
cell cycle including cell division and to detect DNA damages. The checkpoint
protein complex Rad9, Rad1 and Hus1, the ‘9-1-1 complex’ (al-Khodairy et al.,
1994), the other protagonist of this work, is known to be involved in the
checkpoint cascade.  The cellular answer provoked by DNA damage includes the
slowing down of the cell cycle progression and stalling it at the G2/M transition
(reviewed in Foiani et al., 2000), thus providing time to repair damage through
different repair mechanism (reviewed in Christmann et al., 2003) such as base
excision repair (BER), nucleotide excision repair (NER), mismatch repair and
double-strand break repair (DSBR) or complete replication before the cell enters
into mitosis.
2.2 Flap endonuclease 1 (Fen1)
The structure-specific flap endonuclease 1 (Fen1) (Harrington and Lieber,
1994a) is a key enzyme for maintaining genomic stability. It plays an important
role in DNA replication and repair (reviewed in Henneke et al., 2003a). During
DNA replication, it participates in the removal of the displaced RNA-DNA primers
during Okazaki fragment maturation (Hubscher and Seo, 2001). In DNA repair, it
has been implicated in long patch base excision repair and seems to be required
for non-homologous end joining of double-strand DNA-breaks (DSB). Fen1 is
also claimed to be a tumour suppressor when it was shown that Fen1
haploinsufficiency in mice leads to rapid tumour progression (Kucherlapati et al.,
2002, Fodde and Smits, 2002).
92.2.1 Structure-function and post-translational modifications of Fen1
The crystal structure of Fen1 and its homologues from different species
are available (Hwang et al., 1998, Hosfield et al., 1998, Chapados et al., 2004).
Several attempts to solve the structure of human Fen1 (hFen1) were launched
not only in the Hübscher laboratory but until now the structure of human Fen1
(figure 1) as well as the structure of Saccharomyces cerevisiae Rad27p are not
yet available.
Based on protein sequence comparison and biochemical assays, two
major conserved motifs, the N (N-terminal) and I (intermediate) motifs, were
found to be essential for the nuclease activities of Fen1 (Shen et al., 1998,
Harrington and Lieber, 1994b).  A third motif at the C-terminal end is involved in
the interaction with proliferating cell nuclear antigen (PCNA) (Shen et al., 1998,
Stucki et al., 2001, Warbrick et al., 1997). All crystal structures of Fen1
homologues solved to date (Hosfield et al., 1998, Hwang et al., 1998, Ceska et
al., 1996, Chapados et al., 2004) show a conserved helical arch located above
the globular domain that contains the active site. This flexible loop, in addition to
the catalytic site, was shown to be essential for flap cleavage (Storici et al., 2002)
and it has been proposed that the 5′ end of the DNA flap could thread through
the hole of the loop tracking the length of the 5’ tail (Murante et al., 1995). Recent
data suggested that the substrate specificity of Fen1 is conserved in evolution in
Figure 1. Structure and function of flap endonuclease 1 (Fen1). (a) Model building of a 3D
structure of human Fen1 according to Swiss-Pdb Viewer. (b) Functional domains and
important amino acids of  human Fen1 (Reproduced from Henneke et al., 2003a).
(a) (b)
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an extraordinary way and that this conservation is due to the structural similarity
of the hydrophobic wedge in general and the extrahelical 3’flap pocket in
particular (Friedrich-Heineken and Hubscher, 2004). Interaction with an
extrahelical 3’nucleotide helps to position the flap precisely so that an efficient
cleavage of DNA double-flap structure at a precise site can occur and thereby a
ligatable nick for DNA ligase I can be created (Maga et al., 2001).
Fen1 is also a target for two posttranslational modifications in vivo:
acetylation (Hasan et al., 2001) and phosphorylation (Henneke et al., 2003b).
While phosphorylation reduces its endo- and exonucleolytic activities and
abrogates its binding to PCNA thus preventing stimulation of Fen1 by PCNA,
acetylation through the transcriptional coactivator p300 reduces its DNA binding
activity as well as its endo- and exonucleolytic activities.
2.2.2 Fen1 in DNA replication
To maintain the functionality of an organism a continuous reproduction of
the cells is necessary. To provide each of the offspring cells with a complete set
of information for protein syntheses a new reproduction cycle always starts with
the duplication of entire DNA, and this process is called DNA replication.
DNA polymerases (pols) are the key enzymes in this process. All pols
share a common activity, they catalyse the synthesis of DNA macromolecules
from deoxyribonucleoside triphosphates using chemical energy derived from the
hydrolysis of the latter (reviewed in Hubscher et al., 2002).
Once DNA synthesis is initiated at the origin of replication it has to be
continued along the DNA double helix. However the double helix is orientated in
an antiparallel manner. Determined by the structure of various pols, which can
catalyse DNA synthesis exclusively in the 5’ → 3’ direction, only one strand can
be synthesised continuously and is called the leading strand. The opposite
mother strand (called the lagging strand) needs to be synthesised in numerous
short pieces, called the Okazaki fragments. The two DNA strands form a Y-
shaped figure at the point of replication and this arrangement is called the
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replication fork. To solve the sterical problem of antiparallel DNA synthesis on
double-strand DNA a model was proposed where the lagging strand formed a
loop and allowed the pols on both leading and lagging strand to overall progress
in the same direction (Sinha et al., 1980). The completion of DNA synthesis at
the lagging strand requires the removal of RNA primers from Okazaki fragments
before gap-filling synthesis and ligation (Hubscher and Seo, 2001). In this
process Fen1 seems to play an important role. Two models of Okazaki fragment
processing were proposed (figure 2) (reviewed in Henneke et al., 2003a). The
polymerase δ displaces the RNA-containing downstream Okazaki fragment,
creating a 5’flap. This flap can be processed by Fen1 either in a Dna2-dependent
or independent manner depending on the length of the flap (Hubscher and Seo,
2001, Jin et al., 2003). Because the displaced flap by pol δ holoenzyme [pol δ,
PCNA, RF-C] is complementary to the template; it is capable of branch migration
to form numerous interconverting structures. Of these, Fen1 recognises a
double-flap intermediate containing a 1nt 3’-tail with high efficiency and cleaves it
to generate a nicked substrate. Cleavage of a conventional flap substrate leaves
nicked and gapped structures, which would need gap-filling synthesis by a
replicative DNA polymerase before ligation could occur (Maga et al., 2001). Fen1
could be recruited to the site of DNA synthesis by the moving clamp PCNA,
which can stimulate Fen1 by stabilising its interaction to the cleavage site (Tom
et al., 2000) and must be located below the 5’-flap (Jónsson et al., 1998). The
essential PCNA-binding domain was mapped to a region near the basic C-
terminus of Fen1 (Stucki et al., 2001).
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Figure 2. The various functions of Fen1 in Okazaki fragment processing. DNA synthesis
catalysed by pol δ displaces the RNA-containing downstream Okazaki fragment, creating a 5’-
flap. This flap can be processed by Fen1 in either a Dna2-dependent pathway (right) or a Dna2-
independent pathway (left) (Reproduced from Henneke et al., 2003a).
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2.2.3 Fen1 in DNA repair
Fen1 is involved in base excision repair (BER) as well as in double-strand
break repair (DSBR).
BER
BER is the major mechanism for repair of damaged bases in DNA or
apurinic/apyrimidinic (AP) sites (reviewed in Hoeijmakers, 2001). Two different
pathways can then be followed in higher eukaryotes, the long-patch and the
short-patch BER, whereas in mammals the latter is the dominant mode. A
requirement for Fen1 in BER was suggested by genetic experiments in S.
cerevisiae in which RAD27 (homologue of human Fen1) mutants showed high
sensitivity to methylmethane sulfonate (MMS), a DNA alkylating agent (Reagan
et al., 1995). In vitro reconstitution of PCNA-dependent long-patch BER
(Pascucci et al., 1999) with human proteins identified the six factors, AP
endonuclease, replication factor C (RF-C), PCNA, pol δ, Fen1 and DNA ligase I.
The 3’ terminus created by AP endonuclease cleavage serves as the target to
recruit RF-C, which itself assembles PCNA on DNA, followed by the action of pol
δ, Fen1 and DNA ligase I. Fen1 excises the 5’-deoxyribose phosphate group,
together with adjacent 3’-nt(s) as part of an oligonucleotide (Prasad et al., 2000).
Fen1 can recognise and cleave biologically relevant flap substrates that were
assembled into nucleosomes without disrupting histone-DNA interactions
(Huggins et al., 2002). This is also important, as its substrates are likely to be
assembled into chromatin.
DSBR
When DSBs are detected, a complex cascade of reactions is triggered,
aimed at halting the cell-cycle machinery and thereby recruiting repair factors
(see also introduction about the ‘9-1-1 complex’ below). After replication, when a
second identical copy is available, homologous recombination seems to be
preferred; otherwise, cells rely on non-homologous end joining (NHEJ), which is
a more error-prone repair mechanism. The DSBs can create a large set of
different DNA end configurations (among them also flap structures a preferred
substrate for Fen1) which mostly need to be processed by nucleases and pols
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before ligation. The difficulty in identifying the processing enzymes comes from
the fact that the ends can be processed in many different ways; therefore a
genetic knockout of any of the processing components does not block the all
NHEJ pathways. Currently, it is assumed that the endonuclease but not
exonuclease activity of Fen1 is involved in NHEJ (Wu et al., 1999).
2.3 The heterotrimeric checkpoint complex Rad9, Rad1 and
Hus1 (the ‘9-1-1 complex’)
2.3.1 DNA damage checkpoint (reviewed in Melo and Toczyski, 2002)
The DNA damage checkpoint is a signal transduction pathway that blocks
cell cycle progression or slows the rate at which S phase proceeds when DNA is
damaged. It is a surveillance mechanism and is usually not required for cell cycle
events, but enforces their proper order, which is especially critical after acute
DNA damage or DNA replication error. Furthermore the checkpoint pathway
targets the induction of transcription of repair genes, inducible promotion of repair
processes, stabilizes stalled replication forks and executes in the worst case
apoptosis, when the integrity of the genome cannot be ensured anymore.
The checkpoint proteins can be divided into four groups. First the
phosphatindylinositol 3-kinase (PI3K)-like protein kinases, members of this group
are the large protein kinases ATM (Ataxia telangiectasia mutated) and ATR
(Ataxia- and Rad-related). They are thought to bind damaged DNA. Either ATM
and/or ATR are required for each of the DNA-damage-responsive checkpoints.
ATR is constitutively associated with Rad26, which may act as its regulatory
subunit. Second the PCNA-like group, which is a complex of the three proteins
Rad9, Rad1 and Hus1 thought to form a PCNA-like heteromeric trimer called the
‘9-1-1 complex’ that can be loaded directly at sites of DNA damage. The other
two groups contain the two serine/threonine (S/T) kinases – Chk1 and Chk2 –
and their adaptors. Chk1 and Chk2 are thought to be activated by ATM/ATR and
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phosphorylate targets of the checkpoint. The two adaptors proteins bind the S/T
kinases and aid in their activation. If one considers ATM and ATR to act as
‘sensor kinases’ at the top of the DNA damage checkpoint signalling pathway,
the S/T kinases that function downstream in the cascade could be referred to as
the ‘effector kinases’.
2.3.2 The structure and function of the ‘9-1-1 complex’
In S. pompe six checkpoint genes have been identified called Rad1, Rad3
(ATR), Rad9, Rad17, Rad26 (ATRIP) and Hus1 (al-Khodairy and Carr, 1992; al-
Khodairy et al., 1994, Enoch et al., 1992, Rowley et al., 1992)), if no name is
bracketed it is the same for the yeast and the human homologue. These genes
were found to be involved in G2 checkpoint pathway. When it was shown that
many of these genes were conserved from yeast to eukaryotes, it was suggested
that yeast G2 checkpoint signalling mechanisms might be similar to that of
humans.
Rad9, Rad1 and Hus1 have been shown to interact by
immunoprecipitation and by yeast-two-hybrid analysis (Caspari et al., 2000, Hang
and Lieberman, 2000, St Onge et al., 1999, Volkmer and Karnitz, 1999). By size-
exclusion chromatography it has been shown that they interact in a head-to-tail
manner, supporting the model of a circular organisation of these three proteins
(Venclovas and Thelen, 2000). Molecular modelling studies were used to
propose functions for Rad9, Rad1 and Hus1 (Venclovas and Thelen, 2000,
Caspari et al., 2000, Cai et al., 2000). They support the model that Rad9, Rad1
and Hus1 form a heterotrimeric, PCNA-like clamp (figure 3). PCNA is a
homotrimeric ring that is loaded onto DNA by a clamp loader, RF-C in an ATP-
dependent manner (Hubscher et al., 2002, Mossi and Hubscher,1998). Once
loaded, PCNA encircles the DNA as a sliding clamp and tethers replication
proteins. Studies on the ‘9-1-1 complex’ showed that this complex associates
with chromatin after DNA damage (Burtelow et al., 2000). The recruitment of
Rad9 to damage sites depends not only on Rad1 and Hus1, but also upon
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Rad17 (Melo et al., 2001, Kondo et al., 2001). Rad17 is similar in sequence to
the large subunit of RF-C. Mass spectrophotometric analysis of Rad17
complexes in S. cerevisiae showed that Rad17 replaces the large subunit and
exists in a complex with the other four small RF-C subunits (Green et al., 2000).
Several studies showed that the ‘9-1-1 complex’ is loaded onto damaged DNA by
the Rad17 – RF-C(2-5) complex (Majka and Burgers, 2003, Ellison and Stillman,
2003, Bermudez et al., 2003). Once loaded, this Rad9-Rad1-Hus1-complex
could be a platform to allow other enzymes to repair DNA lesions in a processive
manner.
Figure 3.  Structure comparison of PCNA and the ‘9-1-1 complex. 9-1-1 is a heterotrimeric
complex: Rad9 (43kDa), Rad1 (31 kDa), Hus1 (32 kDa). The three subunits interact in a head-to-
tail manner. Structure prediction and transmission electron microscopy showed a PCNA like ring
shape  alternative DNA clamp. (Reproduced from Thelen et al., 1999 and Venclovas et al.,
2000)
17
3 Aim and Project description
The discovery that the three checkpoint proteins – Rad9, Rad1 and Hus1
(the ‘9-1-1’ complex) – share sequence similarity with PCNA has generated
many predictions about the structure and function of these proteins (Venclovas
and Thelen, 2000). From this structural affinity arose also the idea for this thesis
project. PCNA is known to be a functional interaction partner of Fen1. This
interaction is well studied in the Hübscher group (Jónsson et al., 1998, Stucki et
al., 2001). Direct interaction was shown by pulldown experiment and
immunoprecipitation. It was also demonstrated that Fen1 is highly stimulated by
PCNA on a single flap as well as on a double flap substrate. This mechanism is
notably important in DNA replication. The idea was to test if the three checkpoint
proteins Rad9, Rad1 and Hus1 as a complex as well as individually could bind to
Fen1 and what could be the functional consequences of such an interaction. The
focus during this thesis project was clearly more on the interaction part than on
the functional part. The first task was to clarify if the two proteins could interact
directly or indirectly, for this pull down assays and  Far Western Blots had to be
established and optimized. Moreover the behaviour of several Fen1 mutants was
tested under different conditions. Finally the impact of Fen1’s posttranslational
modifications on the Fen1/9-1-1 interaction was studied.
This thesis work was part of the ‘9-1-1 project’ under the supervision of Dr.
Magali Toueille with the final goal to learn more on the role of the ‘9-1-1 complex’
in DNA repair.
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4 Material and Methods
4.1 Nucleic acid substrates
Oligonucleotides for preparing the substrates for Fen1 nuclease assays
were purchased from Microsynth GmbH (Balgach, Switzerland) and their
sequences are listed in table I. The oligonucleotide Ft2_01 was labelled at the 5′
end using [γ-32P]ATP and T4 polynucleotide kinase and its recommended
reaction buffer [70 mM Tris-HCl (pH 7.6), 10 mM MgCl2, 5 mM DDT] from New
England Biolabs. The reaction was incubated at 37°C for 45 min and the enzyme
inactivated by heating to 80°C for 15 min. Free ATP was removed on MicrospinTM
G-25 columns. To generate the substrates for the nuclease assays, the
appropriate oligonucleotides were mixed in a 1:1 molar ratio in 20mM Tris-HCl
(pH 7.4), 150 mM NaCl, heated to 75°C and slowly cooled down to room
temperature. The substrates for the electromobility shift assays were also
prepared according to this protocol.
Table I. Oligonucleotides to create Fen1 substrates used in this study
Oligonucleotide Size Sequence (5′ to 3′)
Upstream primer
Ft2_02 30-mer TCGAGGTCGACGGTATCGATAAGCTTGATA
Downstream primer
Ft2_01 39-mer GTCATGATAGATCTGATCGCTCGAATTCCTGCAGCCCGG
Template
Ft2_04 49-mer CCGGGCTGCAGGAATTCGATATCAAGCTTATCGATACCGTCGACCTCG
A
Unannealed nt are documented in bold.
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4.2 Proteins
4.2.1 Fen1
Human Fen1 cDNA was cloned into the pET 23d vector (Novagen) (Stucki
et al., 2001). The ΔP and the ΔC mutants were purified as described previously
(Stucki et al., 2001). Wt and mutant proteins were overexpressed in the E. coli
strain BL21(DE3)pLysS as histidine-tagged proteins. The cells were grown in 1 l
of LB medium and induced with 0.5 mM ITPG when OD600nm= 0.5 – 0.7 was
reached. After 3 h at 37°C the cultures were centrifuged 20 min at 4,500 rpm
using a G6000 rotor (Sorvall© Instruments) and the remaining pellet from 1 l
culture was re-suspended in 30 ml buffer A [50 mM Tris-HCl (pH 8.0), 300 mM
NaCl, 20 mM imidazole, 1 mM PMSF] and sonicated (Branson Sonifier cell
disruptor 1315) [duty cycle 60°, 2 x 15-25 pulses]. After centrifugation at 20,000
rpm using a SS34 rotor (RC5C, Sorvall© Instruments) for 30 min at 4 °C the
supernatant was filtered (FP 30/0,45 CA-S, Schleicher&Schuell) and loaded on a
Nickel charged metal chelating resin (HiTrap, Amersham Pharmacia Biotech).
For this and all subsequent purification steps fast protein liquid chromatography
(FPLC, Amersham Pharmacia Biotech) was used. Before and after loading the
column was washed with buffer B [50 mM Tris-HCl (pH 8.0), 300 mM NaCl, 20
mM imidazole]. Bound proteins were eluted with a linear imidazole gradient from
20 to 500 mM. The fractions were analyzed on Coomassie stained SDS-PAGE
(Acrylamide/Bis, solution (37.5:1), 40% [w/v] (Serva)) and pooled according to
this. The pool of the peak-fractions was diluted 1:10 in buffer C [10 mM Tris-HCl
(pH 7.6), 1 mM DTT, 10% [v/v] glycerol] and injected to a SP-Sepharose®
column (Amersham Pharmacia Biotech). Bound proteins were eluted with a
linear NaCl gradient from 0.03 to 1.0 M in the same buffer. The fractions were
analyzed by SDS-PAGE and those showing most homogeneity were pooled and
dialyzed into storage buffer [20 mM Tris-HCl (pH 7.6), 0.01% [v/v] NP-40, 0.5
mM EDTA, 1 mM DTT, 60% [v/v] glycerol] using dialysis cassettes (Slide-A-
Lyzer®10K, Pierce).
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4.2.2 ‘9-1-1 complex’
The ‘9-1-1 complex’ was isolated by co-expressing the three baculovirus
encoding the recombinant hRad9, hRad1 and hHus1 in Sf9 cells (provided by T.
Tsurimoto, Japan). A protocol slightly modified from the one published by Shiomi
et al., 2002 was used. 72 h after infection, 1x108 cells were lysed with 0.5% [v/v]
NP-40 in 10 ml buffer B [50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA,
10% [v/v] glycerol, 10 mM DTT, 1 mM PMSF, 20 µg/ml leupeptin, 2 µg/ml
pepstatin, 2 µg/ml bestatin] at 0 °C for 30 min and centrifuged at 20,000 rpm
using a SS34 rotor (RC5C, Sorvall© Instruments) for 2 h at 4 °C. The resulting
lysate was either used as ‘9-1-1 extracts’ for PD experiments or loaded on to a
DEAE Sepharose® column (Amersham Pharmacia Biotech) equilibrated with
buffer H [25 mM HEPES-NaOH (pH 8.1), 1 mM EDTA, 10% [v/v] glycerol, 0.01%
[v/v] NP-40, 1 mM DTT, 0.1 mM PMSF, 2 µg/ml leupeptin, 2 µg/ml pepstatin,
2 µg/ml bestatin] containing 0.1 M NaCl. After washing the column with 0.1 M
NaCl, bound proteins were eluted with buffer H containing 0.4 M NaCl. Rad9-,
Hus1- and Rad1-containing fractions were determined by monitoring the UV
absorption. At this stage, Rad9, Hus1 and Rad1 were the major components of
the fractions. Pooled fractions were diluted 1:4 in buffer H containing 0.1 M NaCl
and loaded on to a Q-Sepharose® column (Amersham Pharmacia Biotech).
Bound proteins were eluted with a linear NaCl gradient from 0.1 to 0.6 M in the
same buffer. Fractions containing Rad9, Hus1 and Rad1 were pooled according
to the result obtained by Western Blot analysis. This pool was called ‘9-1-1’ QS.
The pool was dialyzed in 9-1-1 storage buffer [25 mM HEPES (pH 8.1), 1 mM
EDTA, 20% [v/v] glycerol, 100 mM NaCl, 1 mM β-mercaptoethanol, 0.1 mM
PMSF, 2 µg/ml leupeptin, 2 µg/ml pepstatin, 2 µg/ml bestatin] using dialysis
cassettes (Slide-A-Lyzer®10K, Pierce).
According the same protocol as for the ‘9-1-1 extract’ extracts from Sf9
cells overexpressing only one of the three subunits either Rad9, Rad1 or Hus1
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were obtained. For negative controls extract from mock-infected Sf9 cells was
used.
4.2.3 PCNA
Human PCNA was produced in E. coli strain BL21(DE3)pLysS using the
plasmid pT7/hPCNA (Schurtenberger et al., 1998). PCNA was isolated from 1 l
culture in LB medium. The cells were induced with 0.5 mM ITPG when OD600nm=
0.8 was reached. After 4 h at 37°C the cultures were centrifuged 20 min at 4,500
rpm using a G6000 rotor (Sorvall© Instruments) and the pellet was re-suspended
in 20 ml buffer A [20 mM Tris-HCl (pH 6.8), 25 mM NaCl, 1 mM EDTA, 0.01%
[v/v] NP-40, 1 mM DTT, 10 mM NaHSO3, 1 mM PMSF] and sonicated (Branson
Sonifier cell disruptor 1315) [duty cycle 60°, 15-25 pulses]. After centrifugation at
20,000 rpm using a SS34 rota rotor (RC5C, Sorvall© Instruments) for 30 min at
4 °C the supernatant was loaded on a cellulose phosphate P11 column
(Whatman) connected to a Q-Sepharose® Fast Flow column (Amersham
Pharmacia Biotech). Both columns were equilibrated in buffer QS [20 mM Tris-
HCl (pH 6.8), 1 mM EDTA, 10 mM NaHSO3, 0.01% [v/v] NP-40, 10% [v/v]
glycerol]. The columns were washed twice with buffer QS with additional 100 mM
NaCl, plus twice only the Q-Sepharose® Fast Flow column was washed. Bound
proteins were eluted with a linear NaCl gradient from 0.1 to 0.75 M. The fractions
were analyzed on Coomassie stained SDS-PAGE (Acrylamide/Bis, solution
(37.5:1), 40% [w/v] (Serva) and pooled according to this. For all further
purification steps FPLC (Amersham Pharmacia Biotech) was used. The pool of
the peak-fractions was adjusted to 1 mM CaCl2 and injected to a Econo-Pac
®
CHT-II (hydroxyapatite) column (Bio-Rad Labotatories) previously equilibrated
with CHT I buffer [10 mM Tris-HCl (pH 6.8), 300 mM NaCl, 5% [v/v] glycerol].
The column was washed twice, once with CHT II buffer [10 mM Tris-HCl (pH
6.8), 1 mM MgCl2, 5% [v/v] glycerol] and once with CHT III buffer [10 mM Tris-
HCl (pH 6.8), 50 mM NaCl, 5% [v/v] glycerol]. Bound proteins were eluted with a
linear NaPO4 gradient from 0.0 to 0.25 M in the same buffer. The fractions were
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analyzed by SDS-PAGE and those showing most homogeneity were pooled and
dialyzed in storage buffer [25 mM Tris-HCl (pH 7.5), 50% [v/v] glycerol, 50 mM
NaCl, 1mM EDTA, 1 mM DTT].
4.2.4 GroEL
GroEL (only apical domain) was kindly provided by Erica Friedrich-
Heineken and purified as described in her diploma work, (Friedrich-Heineken E.,
“Refolding of a small subunit of RF-C using immobilized GroEL mini-
chaperones”, Diploma University of Zurich, 2000).
4.2.5 GST-p300-HAT
The GST-tagged HAT domain of p300 was kindly provided by Christine
Bürki (this Institute).
4.2.6 GST-p300 #4
The GST-tagged fragment number 4 (#4) (aa 1’459-1’892) of p300 was
kindly provided by Michael Hottigers group (this Institute). It was described in
Hasan et al., 2001.
4.3 Fen1 nuclease assay
The assay conditions were identical to those published in Friedrich-
Heineken et al., 2003. The enzyme-titration assays were performed in a final
volume of 12.5 µl containing the following ingredients: 40 mM Tris-HCl (pH 7.5)
or 50 mM Bis-Tris (pH 6.5), 10 mM MgCl2, 1 mM DTT, 200 µg/ml BSA and 50
fmol of DNA substrate. After addition of Fen1 wt, reactions were incubated for 15
min at 30°C and stopped with a 2.5x stop buffer (95% [v/v] formamid, 20 mM
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EDTA, 0.05% [w/v] each bromophenol blue and xylene cyanol). The remaining
substrates were denatured by heating to 95°C for 4 min. Products were
separated on 15% denaturing polyacrylamide (Acrylamide/Bis-acrylamide, 19:1
mixture, 40% [w/v] (Qbiogene)) gels containing 7 M urea (BioRad gel apparatus)
and visualised by autoradiography. The X-ray film (Contatyp, Typon Imaging AG)
was exposed for 2 h at –80°C using a highly sensitive screen (Okamato). For
PCNA stimulation of Fen1, the reactions were performed as described above
except that 100 mM NaCl was added to the buffer, this allows the detection of
Fen1 stimulation by PCNA (Jónsson et al., 1998). For the influence of the ’9-1-1
complex’ conditions with 0 mM and 100 mM NaCl were tested.
4.4 Electrophoresis mobility shift assay (EMSA) for Fen1
Assay conditions were the same as published in Friedrich-Heineken et al.,
2003. The binding reactions were carried out in a final volume of 20 µl containing:
50 mM Tris-HCl (pH 8.0), 10 mM NaCl, 5 mM EDTA, 100 µg BSA, 4% [w/v]
Ficoll, 50 fmol of labelled substrate and the indicated amounts of Fen1 wt and
PCNA, respectively ‘9-1-1 complex’. After incubation for 10 min at room
temperature, reactions were loaded on 6% polyacrylamide (Acrylamide/Bis-
acrylamide, 19:1 mixture, 40% [w/v] (Qbiogene)) gels containing 0.5x TBE and
run first at 50 V for 45 min and then at 100 V for 90 min (BioRad gel apparatus).
Finally, the bands were visualised by autoradiography. The X-ray film (Contatyp,
Typon Imaging AG) was exposed over night at –80°C using a highly sensitive
screen (Okamato).
4.5 Native Gel
The electrophoresis was performed in 4-20% native polyacrylamide gels
using the Novex® Tris-Glycine Gels (Invitrogen) according to the manufacturer's
instructions. The running buffer [25 mM Tris base, 192 mM glycine, pH 8.3] and
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the sample buffer [100 mM Tris-HCl, 10% [v/v] glycerol, 0.0025% [w/v]
bromphenol blue, pH 8.6] for native gels were also purchased from Invitrogen.
The products on the gel were analysed by Western Blot. The transfer buffer had
additional 0.005% [w/v] SDS included; the gel was shortly pre-incubated in
transfer buffer before blotting.
4.6 In vitro acetylation assay
Fen1 was in vitro acetylated as described before (Hasan et al., 2001). 1
and 4 µg each of purified Fen1 wt or its mutants were incubated with 50 µM [14C]
acetyl coenzyme A [0.05 mCi/ml] (MG 269, Moravek Biochemicals) in 30 µl HAT
buffer [50 mM Tris-HCl (pH 8.0), 10% [v/v] glycerol, 80 mM NaCl, 1 mM DTT, 1
mM PMSF, 10 mM Na-butyrate] at 30°C for 1 h together with 1 µg of purified
GST-p300-HAT. 10x SDS loading buffer was added, the reactions were heated
to 95°C for 4 min and the samples were subjected to a 10 % SDS-PAGE
(Acrylamide/Bis, solution (37.5:1), 40% [w/v] (Serva)) analysis (BioRad gel
apparatus). Gels were stained with Coomassie blue. Before vacuum drying (Gel
Dryer Model 583, BioRad) the signal was enhanced with 1 M sodiumsalicylat and
the bands were visualised by over night exposure to an x-ray film (Contatyp,
Typon Imaging AG).
4.7 Binding assay
Different amounts of Fen1 wt or mutant proteins were bound to 50 µl 50%
[v/v] Ni2+-beads (ProBondTM Nickel-Chelating Resin, Invitrogen) in 300 µl PD
buffer [50 mM Tris-HCl (pH 8.0), 80 mM NaCl, 0.025% [v/v] NP-40]. The
reactions were incubated 1 h at 4°C with constant gentle agitation. The beads
were then washed 5 times with 1 ml PD buffer but in addition 10 mM imidazole
was included. Bound proteins were eluted by boiling in a 2x SDS-PAGE loading
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buffer and resolved on a 12% SDS-PAGE (Acrylamide/Bis, solution (37.5:1),
40% [w/v] (Serva)) gel which was subsequently stained in Coomassie blue.
4.8 Pull down assay with (his)6-Fen1
Each step of the PD assay was performed in a final volume of 350 µl. 8 µg
of Fen1 wt or mutant proteins in 300 µl PD buffer [50 mM Tris-HCl (pH 8.0), 80
mM NaCl, 0.025% [v/v] NP-40] were bound on 50 µl 50% [v/v] Ni2+-beads
(ProBondTM Nickel-Chelating Resin, Invitrogen). The reactions were incubated 1
h at 4°C with constant gentle agitation. After centrifuging 2 min at 2000 rpm
(Centrifuge 5417R, Eppendorf) the supernatant was thrown away and the beads
were washed 4 times with 1 ml PD buffer. To prevent unspecific binding, the
beads were pretreated with 10 µg of Sf9 cell extract (2 h incubation at 4°C) and
washed as described above. In a next step the indicated amount of ‘9-1-1
complex’, Sf9 extract, PCNA or p300 were added and again incubated for 2 h at
4°C. The beads were then washed 5 times with 1 ml PD buffer but in addition 10
mM imidazole was included. Bound proteins were eluted by boiling in a 2x SDS-
PAGE loading buffer and resolved on a 12% SDS-PAGE (Acrylamide/Bis,
solution (37.5:1), 40% [w/v] (Serva)) gel. The proteins bound to Fen1 were
detected by Western Blot analysis.
For negative controls reactions were performed with GroEL as described
above except that instead of Fen1 10 µg of GroEL was bound to the beads.
The pull down competition assay was carried out following the same
protocol. For the third incubation step the ‘9-1-1 complex’ and its competitor
protein either PCNA or p300 #4 were added simultaneously, at different ratios
(see Results).
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4.9 Pull down assay with in vitro acetylated (his)6-Fen1
12 µg of purified his-tagged Fen1 wt were in vitro acetylated as described
above using 50 µM unlabled acetyl coenzyme A (Sigma). After 1 h incubation at
30°C the reaction mix was directly added to 50 µl 50% [v/v] Ni2+-beads
(ProBondTM Nickel-Chelating Resin, Invitrogen) in 300 µl PD buffer [50 mM Tris-
HCl (pH 8.0), 80 mM NaCl, 0.025% [v/v] NP-40]. Fen1 was bound to Ni2+-beads
during 1 h at 4°C with constant gentle agitation. The beads were washed four
times, twice with 1 ml PD buffer including 500 mM NaCl and twice with PD buffer
(80 mM NaCl). All further steps were performed as described for PD assay.
4.10 Western Blot
Proteins separated by SDS-PAGE (Acrylamide/Bis, solution (37.5:1), 40%
[w/v] (Serva)) were electroblotted during 2 h at 100 V (BioRad Western Blot
Apparatus) onto nitrocellulose membrane (Osmonics). The transfer buffer [25
mM Tris-Base, 192 mM glycine, 20% [v/v] methanol] had a temperature of 4°C
and was cooled during blotting with ice. After staining 5 min in Ponceau solution
the membrane was cut horizontally in two parts if needed and blocked with TBST
and 5% [w/v] powdered milk. The appropriate antibodies were diluted in TBST
with 2% [w/v] powdered milk. The α Rad9 and the α Hus1 antibodies were kindly
provided by Raimundo Freire, Tenerife (Spain). They were produced in rabbits
and the serums are used in a 1:10,000 dilution. The monoclonal mouse-α PCNA
(PC10), used diluted 1:2,000, the polyclonal goat-α Rad1 (N-18), used diluted
1:500, and the polyclonal rabbit-α GST (Z-5), used diluted 1:5,000, antibodies
were purchased from Santa Cruz Biotechnology, California. The membranes
were incubated with the primary antibody either 3 h at room temperature or over
night at 4°C and then 3 times 5 min washed with TBST. Finally the corresponding
HRP-conjugated secondary antibody (donkey anti-goat IgG diluted 1:2,500
(Santa Cruz Biotechnology), anti-rabbit Ig diluted 1:5’000 and anti-mouse Ig
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1:5,000 (Amersham Pharmacia Biotech)) in blocking solution, was added, the
membrane incubated for 1 h at room temperature, followed by 3 times 5 min
washings with TBST (0.05% [v/v] Tween 20) and 10 min with TBS. Antibodies
bound to the proteins were detected by Uptilight HRP Blot Chemiluminescent
Substrate (Uptima) followed by exposure to an X-ray film (Contatyp, Typon
Imaging AG).
4.11 Far Western Analysis
According to the protocol published in (Wu et al., 2000). Increasing
amounts (0.5 µg, 0.75 µg, 1µg) were dissolved on a 12% SDS-PAGE
(Acrylamide/Bis, solution (37.5:1), 40% [w/v] (Serva)) and then electroblotted
during 1.5 h at 100 V (BioRad Western Blot Apparatus) onto nitrocellulose
membrane (Osmonics). The transfere buffer [25 mM Tris-Base, 192 mM glycine,
20% [v/v] methanol] had a temperature of 4°C and was cooled during blotting
with ice. After staining 5 min in Ponceau solution the membrane was cut
vertically along the lanes. The membranes were immersed twice in denaturation
buffer [6 M guanidine-HCl in PBS] for 10 min and then incubated six times for 10
min in serial dilutions (1:1) of denaturation buffer supplemented with 1 mM DTT.
Afterwards they were blocked for 30 min at 4°C with TBST (containing 0.3% [v/v]
Tween 20) and 10% [w/v] powdered milk before being incubated 1 h at 4°C with
Rad9, Rad1 or Hus1, two dilutions of each were used 50 respectively 100 µg/ml.
The proteins were diluted in TBST (containing 0.3% [v/v] Tween 20)
supplemented with 0.25% [w/v] powdered milk, 1 mM DTT and 1 mM PMSF. The
membranes were washed four times for 10 min each in TBST (containing 0.3%
[v/v] Tween 20) with 0.25% [w/v] powdered milk. The second wash contained
0.001% [v/v] glutaraldehyde. Conventional Western Blot analysis was then
performed as described above to detect Rad9, Rad1 and Hus1 bound to Fen1.
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5 Results
5.1 Rad9, Rad1 and Hus1 form a heterotrimeric complex
The three checkpoint proteins Rad9, Rad1 and Hus1 were purified from
Sf9 cells infected with baculovirus (see Materials and Methods). With Western
Blot analysis it could easily been demonstrated, that if the ‘9-1-1 complex’ is
purified from triple infected Sf9 cell extract, the three subunits are co-eluted
(figure 4a), but the results did not give any information about complex formation
among the three proteins. To answer this question samples of extracts from
single and triple infected Sf9 cells were resolved on native gradient gels and
analyzed by Western Blot (figure 4b). In the lanes were the ‘9-1-1 extract’ was
loaded, bands for Rad9, Rad1 and Hus1 appeared at the same position. This
suggested that in extract from triple infected Sf9 cells, Rad9, Rad1 and Hus1
form a complex. For all fractions positive signals could also immunologically be
detected at the position of the subunits, because not all monomers are integrated
in a complex.
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5.2 The purified ‘9-1-1 complex’ contains a nuclease activity
From previous studies it is evident that the biochemical characteristics of
Fen1 are well known (reviewed in Henneke et al., 2003a). Among these data it
was also shown that PCNA is one of the important interaction partner of Fen1
and that the Fen1 activity is stimulated by PCNA (Shen et al., 1998, Stucki et al.,
2001, Warbrick et al., 1997). PCNA on the other hand has sequential and
structural similarities to the checkpoint protein complex Rad9, Rad1 and Hus1
(called ‘9-1-1 complex’) (Venclovas and Thelen, 2000), this gave the idea to
perform experiments with Fen1 and the ‘9-1-1 complex’ in order to test the effect
of the latter on the Fen1 activity and compare it to the stimulatory effect of PCNA.
In a first set of experiments various parameters (pH, NaCl concentration) were
Figure 4. (a) Purification of the ‘9-1-1’ complex. The ‘9-1-1 complex’ fraction QS was
purified over two columns, first a DEAE Sepharose and second a Q-Sepharose. In lane 1,
respectively 3, samples of the loads were resolved, lanes 2 and 4 shows the corresponding
flow through (FT) fractions. The complex was purified with FPLC system and after the Q-
Sepharose column fractions of 250 µl were collected and analyzed by WB. The three panels
show the membranes developed with the three antibodies αRad9, αRad1 and αHus1. The
three subunits were co-eluted in fractions 25 to 35, which were pooled to the ‘9-1-1’ QS
fraction. (b) Native gradient gel. Samples of extract from single and triple infected Sf9 cells
were analyzed by WB from a native gradient gel. The amount of the extract from triple infected
cells is three times the amount of extract form single infected cells. Two different amounts of
each extract were loaded. At the position of about 110 kDa (marked with an arrow) a band
appears on all three panels (αRad9, αRad1 and αHus1) in the lanes were extract from triple
infected cells were loaded. On the panel in the middle (αRad1) it is obvious that together with
the complex (position of the arrow) also free subunits are co-existing visible (at the bottom of
the gel).
(a) (b)
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tested in a Fen1 single flap endonuclease assay (see Materials and Methods).
The published results for the stimulatory effect of PCNA on Fen1 could be
reproduced (figure 5a).
For the ‘9-1-1 complex’ in yeast, the Ddc1, Mec3 and Rad17 complex, it
was shown that these three proteins as a complex have no exonuclease activity
(Giannattasio et al., 2004), an exonuclease activity was only claimed for human
Rad9 alone (Bessho and Sancar, 2000). However in a Fen1 activity assay the ‘9-
1-1 complex’ alone seems to cleave the substrate unspecifically (figure 5). One
main product could be observed with an estimated length of about one nt (no
marker were used in this experiment). Additional 100 mM NaCl apparently
decreases this nuclease activity to about 30 %, whereas at pH 7.5 the efficiency
is only slightly better than at pH 6.5. The ‘9-1-1 complex’ seems to have an
inhibitory effect on the Fen1 activity, but the result could also be interpreted as
competition between the two nuclease activities for the same substrate and so
this did not allow drawing any conclusions about the effect of the ’9-1-1 complex’
on Fen1. About the nature of this additional nuclease only speculation is
possible, it looks like it is a 5’   3’ exonuclease. Data from the literature
suggested that this nuclease activity does not belong to the ‘9-1-1 complex’ but
rather to a co-purified nuclease. The purification of ‘nuclease-free 9-1-1 complex’
was repeated. The data obtained confirm the hypothesis of a co-purified
nuclease. To remove this nuclease appears to be very tricky. Further studies are
required to solve this problem.
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PCNA can also stimulate Fen1 binding to DNA (Tom et al., 2000). Next
this effect was studied by electro mobility shifting assays (EMSA) (see Materials
and Methods). Again the goal was to compare PCNA and the ‘9-1-1 complex’.
The results published by Bambara’s group could not be reproduced but an effect
of the ‘9-1-1 complex’ could be observed. For EMSA the partially purified QS
fraction of the ‘9-1-1 complex’ was used (see Materials and Methods). In an
EMSA the ’9-1-1 complex’ alone without Fen1 gave a shift. With 20 ng of Fen1
and 1 µg of ‘9-1-1 complex’ two bands appeared. This might be either a Fen1-
DNA or a lighter ‘9-1-1’-DNA complex (figure 6). This result raised the question
whether the ‘9-1-1 complex can bind to DNA even without the clamp loader
Figure 5. PCNA and the ‘9-1-1 complex’ influence Fen1 activity differently. A single flap
(SF) substrate as drawn was used for the Fen1 activity assays. The optimal conditions for
PCNA stimulation are known to be at pH 6.5 with 100 mM NaCl (left panel lane 1 to 6). The
NaCl is required to inhibit Fen1 and to make the stimulation possible. When the ‘9-1-1
complex’ was added to the reaction a decrease of the Fen1 product (21 nt) could be observed,
but at the same time an additional product increased at the position of about 1 nt. The effect
occured at pH 6.5 as well as at pH 7.5. NaCl seems to have only a slight inhibitory influence.
The additional product was probably cleaved by a co-purified exonuclease. In lane 18 the
volume of the ‘9-1-1 complex’ was substituted by ‘9-1-1’ storage buffer. Lane 15, PCNA from
an other purification was tested.
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RF-C/Rad 17 or if the effect was due to the co-purified putative nuclease, which
could also be responsible for the second band in the last lane. To answer this
questions again ‘nuclease free 9-1-1 complex’ is required.
5.3 Fen1 wt interacts with the ‘9-1-1 complex’ and with each of
the three subunits Rad9, Rad1 and Hus1
Next the focus was to characterize the interaction between Fen1 and the
‘9-1-1 complex’. The first task was to optimize the conditions for a Ni2+-pulldown
(PD) experiment (see Materials and Methods) with purified His-tagged Fen1 and
extracts from Sf9 cells that were triple infected with Rad9, Rad1 and Hus1. The
optimal buffer conditions were 80 mM NaCl, 0.025% NP-40. In a binding assay
(see Materials and Methods) different amounts of purified proteins were bound to
Ni2+-beads. They were: first Fen1 wt (Harrington and Lieber, 1994a); second
Fen1 ΔC, a mutant lacking the last 21 aa (aa 360-380 lacking) at the C terminus
(Stucki et al., 2001); third Fen1 ΔP, a mutant lacking the PCNA interaction motif
Figure 6. The ‘9-1-1 complex’ can bind to single flap (SF) DNA. An Electro mobility shift
assay (EMSA) was done as described in ‘Materials and Methodes’. Lane 1: no enzyme
control, single flap (SF) substrate; lane 2: positive control, an excess of Fen1 was added to
see the position of the Fen1-shift. In lanes 4 – 6 ‘9-1-1 complex’ and the SF substrate were
incubated. The ‘9-1-1 complex’ alone provoked a shift at the same position as 10 or 20 ng of
Fen1. With the same amounts of PCNA as ‘9-1-1 complex’ no shift appears (lanes 8 – 10 and
15 – 17).)
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(aa 337-344 lacking) (Stucki et al., 2001); fourth Fen1 D86A, an active site
mutant which has a single aa replaced (Stucki M. and Hübscher U., unpublished
data) and finally fifth His-tagged GroEL, the apical domain (aa 191-376) of a
bacterial chaperon protein, which was used as a negative control. The binding
assay gave information about the necessary amount of proteins to cover the
beads (figure 7).
At the beginning problems with unspecific binding of the ‘9-1-1 complex’
proteins to the Ni2+-beads and to GroEL were evident. This could be avoided by
an additional step during the PD experiment. After the His-tagged proteins were
bound to the Ni2+-beads, the beads were washed with PD buffer and then
incubated with the same amount of extract from mock infected Sf9 cells as in the
third incubation step where extracts of infected Sf9 cells were used. Under
optimal conditions (see Materials and Methods) Fen1 wt bound to Ni2+-beads
interacted with the ‘9-1-1 complex’ from Sf9 cell extract as well as with the ‘9-1-1’
QS (figure 8c). To test the strength of this interaction the experiments were
repeated under more stringent conditions by increasing the NaCl and the NP-40
Figure 7. Optimisation of the Ni2+-beads binding assay. On the left panel different amounts
of Fen1 wt  and GroEL were bound to Ni2+-beads. The beads were washed and the elution
resolved on a 12% SDS-PAGE. For PD experiments 8 ng of each were bound to 25 µl dry
Ni2+-beads. On the right panel 8 ng of Fen1 wt and GroEL were bound to beads as reference
values, to which the different amounts of Fen1 ΔC and Fen1 D86A were compared. In PD
experiments 15 ng of Fen1 ΔC and 8 ng of Fen1 D86A were bound to the beads. For Fen1 ΔP
the same amounts as for Fen1 ΔC were chosen because they have the same binding capacity
for Ni2+-beads (data not shown).
µg µg
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concentrations in the washing buffer (see Materials and Methods). The signal
appearing on the film after developing the WB analyze was as intense as before
even when a washing buffer containing concentrations of 150 mM NaCl and
0.1% NP-40 was used (figure 9). This suggested that Fen1 and the ‘9-1-1
complex’ are interacting very strongly. The PD experiment was analyzed by
Western Blot (WB) (see Materials and Methods) which were developed with
antibodies (AB) against Rad9, Rad1 and Hus1. From these results it was
concluded that Fen1 wt and the ‘9-1-1 complex’ interacted directly.
Next it was tested which of the three subunits of the ‘9-1-1 complex’ is
responsible for this interaction. A PD experiment under the same conditions as
described before was executed where extracts from singly infected Sf9 cells
containing Rad9, Rad1 and Hus1 respectively were tested as interaction partners
of Fen1 wt. Surprisingly all three subunits gave a positive signal when the PD
assay was analyzed by WB (figure 8a). These findings were confirmed by a Far
Western blot analysis (see Materials and Methods) (figure 8b).
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(a)
Figure 8. Fen1 interacts with the ‘9-1-1 complex’ as well as with the three individual
subunits Rad9, Rad1 and Hus1. (a) On the left panel is the positive control of the PD
assays, the interaction of Fen1 wt with PCNA gives a positive signal in the WB developed with
αPCNA antibody. As a negative control the experiment was performed with Fen1 wt and
extract from mock infected Sf9 cells. More controls were done with beads only or GroEL
bound to beads, which were incubated with ‘9-1-1’ extract. The results were analyzed by WB
using antibodies against Rad9, Rad1 and Hus1. Finally when the interaction of Fen1 wt with
‘9-1-1’ extract was tested, a signal appears for all three antibodies. The same result was
obtained when Fen1 wt was incubated individually with extract from each of the subunits
Rad9, Rad1 and Hus1. (b) The interaction with the three subunits individually was confirmed
by a Far Western experiment. Different amounts of Fen1 wt were loaded on a gel and blotted
onto a nitrocellulose membrane, which was subsequently incubated with dilutions of extract
from single infected cells. Finally a WB using antibodies against Rad9, Rad1 and Hus1 was
performed. An arrow on all three panels mark the position of Fen1, the signal is due to the ‘9-
1-1’ antibodies. As a positive control PCNA was used. (c) Binding of the ‘9-1-1’ QS and ‘9-1-1’
extract to Fen1 was compared. In a PD assay they showed about the same binding capacity.
Simultaneously the interaction of the ‘9-1-1 complex’ with several Fen1 mutants was tested.
The binding to Fen1 ΔC gives a weaker signal (lanes 6 and 12).
(b) (c)
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5.4 Fen1 likely interacts with the ‘9-1-1 complex’ through its C-
terminus
The three Fen1 mutants described above, Fen1 ΔC, Fen1 ΔP and Fen1
D86A, were tested in the Fen1/’9-1-1 complex’ interaction study hoping to get a
first hint where on Fen1 the binding site for the ‘9-1-1 complex’ is located. They
were tested in a PD assay under optimal and also more stringent conditions and
compared to Fen1 wt binding to the’9-1-1 complex’ (figure 9). Binding of the ‘9-1-
1 complex’ to Fen1 ΔC was weaker than to Fen1 wt. Between Fen1 wt and ΔP no
difference in the binding capacity could be observed (figure 8c). The active site
mutant of Fen1 interacted only slightly weaker with the ‘9-1-1 complex’ than the
wild type, this mutant can therefore be used as a negative control for further
functional studies with Fen1 and the ‘9-1-1 complex’, in which the activity of Fen1
is not wanted.
These data suggested that PCNA and the ‘9-1-1 complex’ don’t bind to the
same region of Fen1 and that the C-terminus of Fen1 might be important for the
interaction with the ‘9-1-1 complex’. When the interaction of Fen1 ΔC with the
Figure 9. Fen1 interacts with the ‘9-1-1 complex’ also under more stringent conditions.
Fen1 wt was bound to Ni2+-beads and then incubated with ‘9-1-1’ QS. Washing buffers with
increased concentrations of NP-40 and NaCl were tested. Higher NP-40 and/or NaCl
concentrations do not prevent the Fen1/9-1-1 interaction.
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three monomers of the ‘9-1-1 complex’ Rad9, Rad1 and Hus1 was tested it
turned out that Rad9 was strongly interacting, whereas Rad1 and Hus1 were
hardly binding to Fen1 ΔC (figure 10).
To support this hypothesis PD competition assays were performed. First,
Fen1 was bound to Ni2+-beads then increasing amounts of two competitor
proteins were added and incubated simultaneously. PCNA and the partially
purified ‘9-1-1 complex’ QS fraction were tested as competitors in a first
experiment. 1.7 µg of ‘9-1-1 complex’ was compared to 0.46 µg of PCNA; this is
a molar ratio PCNA to ‘9-1-1 complex’ of 1:3.4. PCNA was increased to 0.92 µg
and 1.84 µg, ‘9-1-1 complex’ was kept at a constant amount. Vice versa a
constant amount of 0.46 µg of PCNA was compared to 3.4 µg and 6.8 µg of ‘9-1-
Figure 10. Interaction of Fen1 ΔC with the three subunits of the ‘9-1-1 complex’. A PD
assay with Fen1 ΔC and extract from single infected Sf9 cells was performed. The two lanes
in the middle show the input of ‘9-1-1’ QS and the interaction of Fen1 ΔC and the ‘9-1-1’ QS.
Fen1 ΔC binds to the Rad9 subunits (upper panel on the right) but hardly to Rad1 (middle
panel on the left) and Hus1 (bottom panel on the right).
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1 complex’. The PD assay was analyzed by WB, and the data indicated that as
expected no competition could be observed (figure 11a). These data supported
the assumption that the PCNA binding site of Fen1 is likely not involved in the
interaction between the ‘9-1-1 complex’ and Fen1.
Finally this experiment was repeated but PCNA was replaced by the
transcriptional coactivator p300 fragment #4 (overexpressed in E. coli), which is
known to interact with Fen1 at its C-terminus (Hasan et al., 2001). The amounts
of ‘9-1-1 complex’ were the same as indicated before, for p300 fragment #4 25
µl, 50 µl and 100 µl of E. coli extract were used. As predicted a competition
between the ‘9-1-1 complex’ and p300 to Fen1 took place. When the amount of
p300 was increased the signal of the ‘9-1-1 complex’ on the WB decreased and
vice versa (figure 11b). The conclusion drawn from this experiment was that the
C-terminus of Fen1 is likely involved in binding to the ‘9-1-1 complex’.
Figure 11. p300 and the ‘9-1-1 complex’ compete for Fen1. For this PD competition assays
were performed. (a) For the input (lane 1) PCNA or ‘9-1-1’ QS was loaded. The positive
controls (lane 2) show the interaction Fen1/PCNA and Fen1/’9-1-1’. In lane 3 BSA was added
as a control competitor. In lanes 4 – 8 PCNA and ‘9-1-1’ QS were added as competitors, the
results were analyzed by WB developed against PCNA, Rad9, Rad1 and Hus1. (b) For the
input (lane 1) GST p300 fragment #4 respectively ‘9-1-1’ QS was loaded. The positive controls
(lane 2) show the interaction Fen1/p300 and Fen1/’9-1-1’. In lane 3 GST was added as a
control competitor. In lanes 4 – 8 p300 and ‘9-1-1’ QS were added as competitors, the results
were analyzed by WB developed against PCNA, Rad1 and Hus1. The antibody αRad9 could
not be used, because it was raised against GST-Rad9 and does also crossreact with GST. A
competition between ‘9-1-1’ QS and p300 was evident.
(a) (b)
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5.5 Acetylation of Fen1 reduces the interaction with the ’9-1-1
complex’
From data published from our laboratory it is known that Fen1 acetylation
was enhanced upon UV treatment of human cells and was so classified as
regulatory modification of Fen1. In vitro Fen1 was acetylated by the
transcriptional coactivator p300, which forms a complex with Fen1 (Hasan et al.,
2001). In mammalian cells UV damage of the DNA is basically repaired through
NER, a repair mechanism into which Fen1 is not known to be involved. One
would expect that acetylation of Fen1 should prevent a binding to the ‘9-1-1
complex’, which recruits repair proteins to the UV damage site. To test this
hypothesis Fen1 was acetylated in vitro by p300 and then tested in a PD assay
with the ‘9-1-1 complex’. For this different histone acetyltransferases (HAT) were
tested to acetylate Fen1 in vitro (data not shown). It turned out that purified GST
p300 HAT (Bürki C. and Hottiger M. O., unpublished data) was the most efficient
enzyme when the whole reaction mix was used in a subsequent PD experiment.
To compensate the decreased binding of Fen1 due to the treatment during the
HAT assay, 50% more Fen1 as in previous PD experiments was incubated with
the Ni2+-beads. To get rid of GST p300 HAT the beads were then washed with a
buffer containing 500 mM NaCl, the high salt concentration did not harm the
Fen1 binding to the beads (data not shown). The following steps were the same
as described for PD assays before. The experiment was performed with ‘9-1-1
complex’ QS fraction in as well as with extracts from singly infected (Rad9, Rad1,
Hus1) Sf9 cells.
For the ‘9-1-1 complex’ the signal in the WB was for all three monomers
weaker when the complex interacted with acetylated Fen1 than with mock
acetylated Fen1. The same results were obtained for the Rad1 and the Hus1
subunits. Only the Rad9 subunit gave the same signal for acetylated and mock
acetylated Fen1 (figure12). From these data it was concluded that the acetylation
of Fen1 leads to a decrease of the interaction with the ‘9-1-1 complex’.
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Figure 12. Acetylation of Fen1 reduces the interaction with the ’9-1-1 complex’. A PD
assay was performed. The three lanes in the middle show the input and the interaction of ‘9-1-
1’ QS with acetylated and mock acetylated Fen1wt. The signal for the binding to acetylated
Fen1 is on all three panels (αRad9, αRad1 and αHus1) weaker compared to the mock
acetylated. The same could also be observed for the interaction with Rad1 (middle panel at the
right) and Hus1 (bottom panel at the left) from single infected cell extract. Only for Rad9 (upper
panel at the left) no difference between acetylated and mock acetylated Fen1 was seen.
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6 Discussion
The data presented in this thesis give evidence that the three monomers
Rad9, Rad1 and Hus1 form a heterotrimeric complex in Sf9 cell extract as well as
in the purified fractions. The ‘9-1-1 complex’ is known to have structural similarity
to PCNA, a functional interaction partner of Fen1. The endo- and exonuclease
activity of Fen1 are highly stimulated by PCNA. Unfortunately it was not possible
to measure the effect of the ‘9-1-1 complex’ on Fen1 because a putatively co-
purified nuclease interfered with the Fen1 activity. Improvement of the ‘9-1-1
complex’ purification and further studies are required to solve this problem. What
could be shown, however, was that Fen1 binds to each of the three subunits
individually and also interacts directly with the ‘9-1-1 complex’. Three different
possibilities could explain the fact that all three monomers of the ‘9-1-1 complex’
bind to Fen1. First three Fen1 molecules can bind when Rad9, Rad1 and Hus1
appear as a complex, second the Fen1 binding site on the ‘9-1-1 complex’ is
spread over the three subunits or third, physiologically only one subunit of the
complex interacts with Fen1 because the other binding sites are occupied after
complex confirmation.
A competition experiment with the ‘9-1-1 complex’ and PCNA
demonstrated that the two ring-structured trimers can bind simultaneously and
that they are not competing for the same interaction site on Fen1. The same
experiment where PCNA was substituted by p300, a protein known to bind at the
Fen1 C-terminus, showed that Fen1 C-terminus is crucial for the Fen1/9-1-1
interaction. This data was further supported by a result from a PD experiment
with the Fen1 ΔC mutant, with which the ‘9-1-1 complex’ interacted only very
weakly. And again this notion is fortified by the facts that the Fen1 homologue in
Archaea does not contain this C-terminus and that this early organisms do not
express any checkpoint proteins. It could therefore be possible that the C-
terminus of Fen1 was developed later in evolution inter alia for the interaction
with checkpoint proteins.
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The data of this work further support the assumption that the PCNA-like
checkpoint protein ‘9-1-1 complex’ is a novel interaction partner of Fen1. This
signifies that Fen1 could be involved in the checkpoint pathway or that the ‘9-1-1
complex’ as a checkpoint protein provides a platform for repair enzyme
recruitment to DNA lesions. The observation that the ‘9-1-1 complex’ physically
interacts with pol β in vitro and that it has a stimulatory effect on the DNA
polymerase activity (Toueille et al., submitted, 2004) strengthens this hypothesis.
Pol β is a key player in BER and is known to interact with Fen1 (El-Andaloussi N.
and Hottiger M.O., unpublished data). To establish the complete in vitro
reconstitution of BER could help to elucidate the exact role of the ‘9-1-1
complex’, Fen1, pol β and other auxiliary proteins (RF-C, PCNA, DNA ligase I).
UV damages in mammal cells are usually repaired through NER. Fen1 is
not known to be involved in NER but previous studies documented that Fen1
acetylation is increased upon UV damage. Assuming that the ‘9-1-1 complex’ is
responsible for the recruitment of repair proteins, it would be logical that in case
of UV damage Fen1 should not be recruited because its not involved in UV
damage repair mechanism and its activity and binding capacity are reduced upon
acetylation. To test if acetylation has an effect on the ‘9-1-1 complex’ binding a
pull down experiment with acetylated Fen1 was performed and the results
confirmed the hypothesis. In further experiments it would be interesting to test
the binding efficiency of other posttranslational modifications of Fen1 and the’9-1-
1 complex’ (e.g. phosphorylation (Henneke et al., 2003b)).
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8 Abbreviations
‘9-1-1 complex’ Heterotrimeric protein complex of Rad9, Rad1 and Hus1
aa amino acid
AcCoA Acetyl coenzyme A
ATP Adenosine-5’-triphosphate
Bis-Tris Bis(2-hydroxyethyl)amino-tris-(hydroxymethyl)-
methane
BSA Bovine serum albumin
cDNA Complementary DNA
DNA Deoxyribonucleic acid
DDT Dithiothreitol
ECL Detection System A non-isotopic method for detecting protein
immobilised on membranes
E. coli Escherichia coli
EDTA Ethylenediaminetetraacetic acid
EMSA Electrophoresis mobility shift assay
Fen1 Flap endonuclease 1
FPLC Fast protein, peptide and polynucleotide liquid
chromatography
GroEL Fragment of a bacterial chaperon protein
GST Gluthadione-S-transferase
HAT Histone acetyl transferase
HEPES 4-(2-Hydroxyethyl)piperazine-1-ethanesulonic acid
His Histidine
HRP Horseradish peroxidase
IPTG Isopropyl-β-D-thiogalactopyranoside
kDa Kilodalton (=1000 Dalton)
LB medium Luria Bertani medium
LMW Low molecular weight marker (protein marker)
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NP-40 Nonidet P-40
nt nucleotide
OD600nm Optical density measured at a wavelength of 600 nm
[γ32P] ATP ATP with radioactively labelled phosphorus in the γ
position
p300 Transcriptional coactivator p300
PBS Phosphate-buffered saline
PCNA Proliferating cell nuclear antigen
PD Pull down assay
PMSF Phenylmethylsulphonyl fluoride
Pol DNA polymerase
Rad Radiation resistance (proteins involved in DNA
checkpoint or repair)
RF-C Replication factor C
RNA Ribonucleic acid
rpm Rotor speed in revolutions per min
S. cerevisiae Saccharomyces cerevisiae (budding yeast)
S. pombe Saccharomyces pombe (fission yeast)
SDS Sodiumdodecyl sulphate
SDS-PAGE SDS-polyacrylamide gel electrophoresis
Sf9 cells Spodoptera frugiperda (insect) cells in culture
TBE Tris-borate EDTA (45 mM Tris-borate (pH 8), 1 mM EDTA)
TBS Tris-buffered saline (10 mM Tris-HCl (pH 7.5), 150
mM NaCl)
TBST TBS with additional 0.05% Tween 20
Tris Tris-(hydroxymethyl)-aminomethane
UV Ultra violet radiation
v/v Volume per volume
WB Western Blot analysis
wt Wild type
w/v Weight per volume
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